40 results
8-K
EX-99.1
CRBP
Corbus Pharmaceuticals Holdings Inc
5 Feb 24
Regulation FD Disclosure
8:12am
, including the potential impact of the recent COVID-19 pandemic and the potential impact of sustained social distancing efforts, on our operations
8-K
EX-99.2
CRBP
Corbus Pharmaceuticals Holdings Inc
26 Jan 24
Regulation FD Disclosure
7:47am
, including the potential impact of the recent COVID-19 pandemic and the potential impact of sustained social distancing efforts, on our operations
8-K
EX-99.1
CRBP
Corbus Pharmaceuticals Holdings Inc
14 Nov 23
Regulation FD Disclosure
5:19pm
, including the potential impact of the recent COVID-19 pandemic and the potential impact of sustained social distancing efforts, on our operations
8-K
EX-99.1
CRBP
Corbus Pharmaceuticals Holdings Inc
3 Aug 23
Other Events
8:44am
, including the potential impact of the recent COVID-19 pandemic and the potential impact of sustained social distancing efforts, on our operations
8-K
EX-99.1
CRBP
Corbus Pharmaceuticals Holdings Inc
21 Dec 22
Corbus Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:35pm
and unknown risks, uncertainties, and other
-2-
factors, including the potential impact of the recent COVID-19 pandemic and the potential impact
8-K
EX-99.1
uz14sw
26 Sep 22
Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of Directors
5:00pm
8-K
EX-99.1
hm9ochnly6sq
9 Aug 22
Corbus Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
12:00am
8-K
EX-99.1
hr4aua9t97tv77a7v
10 May 22
Corbus Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
8:20am
8-K
EX-99.1
8b370f2sn985iml
11 Apr 22
Corbus Presents First Preclinical Data for CRB-601 at the American Association for Cancer Research (AACR) Annual Meeting
9:20am
8-K
EX-99.1
0ul6tn
8 Mar 22
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Updates
8:15am
8-K
EX-99.1
wp65ivi u4i00mlvff
12 Nov 21
Corbus Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
8:15am
8-K
EX-99.1
k6gnto
12 Aug 21
Corbus Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
8:29am
8-K
EX-99.1
4au4htgkzau
24 Jun 21
Corbus Pharmaceuticals Announces Topline Results from determine Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
8:18am
8-K
EX-99.1
43mcub
1 Jun 21
Entry into a Material Definitive Agreement
7:21am